Some persons at high risk of lymphoproliferative diseases = Certaines personnes à haut risque de maladies lymphoproliférativesMILLER, R. W.Progress in cancer research and therapy. 1984, Vol 27, pp 201-205, issn 0145-3726Article

American Society of Hematology twenty-fifth annual meeting, San Francisco, California, December 3-6, 1983. Abstracts = American Society of Hematology. 25ème réunion annuelle, San Francisco, Californie, 3-6 Décembre 1983. RésumésBlood. 1983, Vol 62, Num 5, issn 0006-4971, 311 p.Conference Proceedings

Mise en place d'un registre des hémopathies malignes en Côte d'Or. Premiers résultats = A registry of malignant hematological diseases in the department of Côte d'Or (France)CARLI, P. M; MILAN, C; LORENZINI, J. L et al.Nouvelle revue française d'hématologie. 1983, Vol 25, Num 5, pp 329-335, issn 0029-4810Article

Comment donner le diagnostic d'hémopathie maligne? = How to gives the diagnosis of a malignant hemopathyALBY, N.Actualités hématologiques. 1983, Vol 17, pp 137-140, issn 0567-8757Article

Hematological malignanciesMELLSTEDT, Hakan; BARISTA, Ibrahim; DIMOPOULOS, Meletios et al.Annals of oncology. 2006, Vol 17, issn 0923-7534, x135-x159, SUP10Conference Paper

Pathogenesis of leukemias and lymphomas: environmental influences. Workshop held at the National Institutes of Health, in May 1982 = Pathogenèse des leucémies et lymphomes: influence de l'environnement. Réunion de travail tenue au National Institute of Health, en mai 1982MAGRATH, I. T; O'CONOR, G. T; BRACHA RAMOT, Ed et al.Progress in cancer research and therapy. 1984, Vol 27, issn 0145-3726, XXVIII-399 pConference Proceedings

Histiocytic lymphoma of the stomachDEODHAR, S. D; JAMMIHAL, H. J; KANE, S. V et al.Journal of Postgraduate Medicine (Bombay). 1983, Vol 29, Num 2, pp 117-119, issn 0022-3859Article

The clinical use of antibodies in haematological malignanciesLOPEZ-GUILLERMO, A; MERCADAL, S.Annals of oncology. 2007, Vol 18, issn 0923-7534, ix51-ix57, SUP9Conference Paper

In vitro determination of tumour chemosensitivity in haematological malignanciesBIRD, M. C; BOSANQUET, A. G; GILBY, E. D et al.Hematological oncology. 1985, Vol 3, Num 1, pp 1-9, issn 0278-0232Article

Invasion of the sternum by lymphoma-role of CTSTARK, P.Der Radiologe (Berlin. Print). 1984, Vol 24, Num 3, pp 130-132, issn 0033-832XArticle

Lactate dehydrogenase isoenzyme activity in malignant haematological diseasesPAULE, B; FRANCOUAL, J; LINDENBAUM, A et al.Biomedicine & pharmacotherapy. 1984, Vol 38, Num 1, pp 62-65, issn 0753-3322Article

Precedents for meaningful recovery during treatment in a medical intensive care unit: outcome in patients with hematologic malignancySCHUSTER, D. P; MARION, J. M.The American journal of medicine. 1983, Vol 75, pp 402-408, issn 0002-9343Article

Antiangiogenic therapy in hematologic malignancies : HaematologyMOEHLER, T. M; HILLENGASS, J; GOLDSCHMIDT, H et al.Current pharmaceutical design. 2004, Vol 10, Num 11, pp 1221-1234, issn 1381-6128, 14 p.Article

The use of monoclonal antibodies in clinical haematology. The art of limitationHOKLAND, P.Scandinavian journal of haematology. 1984, Vol 33, Num 1, pp 5-8, issn 0036-553XArticle

Fluorescence polarization as a parameter of plasma lipids in patients with hematologic malignancies = Polarisation de fluorescence, un paramètre des lipides plasmatiques chez les malades atteints de néoplasies hématologiquesSPIEGEL, R. J; SCHAEFER, E. J; MAGRATH, I. T et al.Leukemia research. 1983, Vol 7, Num 5, pp 647-654, issn 0145-2126Article

Significance of chromosome change to hematopoietic neoplasms = Signification des modifications chromosomiques des hémopathies malignesCHAGANTI, R. S. K.Blood. 1983, Vol 62, Num 3, pp 515-524, issn 0006-4971Article

Cytogénétique et hémopathies malignes (à l'exception des lymphomes) = Cytogenetics and malignant hemopathyFENAUX, P; LAI, J. L; KERCKAERT, J. P et al.Lille médical (1987). 1989, Vol 29, Num 1, pp 27-31, 5 p.Article

Les lymphomes malins non hodgkiniens chez le sujet âgé. A propos de 34 observations = Non-Hodgkin lymphomas in elderly patients. A study of 34 casesLEDERLIN, P; BOMAN, F; WITZ, F et al.Annales médicales de Nancy et de l'Est. 1991, Vol 30, Num 2, pp 159-161, issn 0221-3796, 3 p.Article

New sources of drugs for hematologic malignanciesSUKHAI, Mahadeo A; SPAGNUOLO, Paul A; WEIR, Scott et al.Blood. 2011, Vol 117, Num 25, pp 6747-6755, issn 0006-4971, 9 p.Article

SNP array analysis in hematologic malignancies: avoiding false discoveriesHEINRICHS, Stefan; CHENG LI; LOOK, A. Thomas et al.Blood. 2010, Vol 115, Num 21, pp 4157-4161, issn 0006-4971, 5 p.Article

ASH 2002 : nouveautés cliniques et biologiques dans les hémopathies malignesROCHANT, Henri; SIGAUX, François.Hématologie (Montrouge). 2003, Vol 9, Num 2, issn 1264-7527, 39 p., NSSerial Issue

BCR/ABL P190 transgenic mice develop leukemia in the absence of CrklHEMMERYCKX, Bianca; REICHERT, Anja; WATANABE, Meguru et al.Oncogene (Basingstoke). 2002, Vol 21, Num 20, pp 3225-3231, issn 0950-9232Article

CML: Molecular mechanisms & therapeutic strategiesARLINGHAUS, Ralph B.Oncogene (Basingstoke). 2002, Vol 21, Num 56, issn 0950-9232, 141 p.Serial Issue

Meeting of the European Haematology AssociationBritish journal of haematology. Supplement. 1996, Vol 93, Num 2, issn 0963-1860, 397 p.Conference Proceedings

2-chlorodeoxyadenosine treatment of lymphoid malignanciesPIRO, L. D.Blood. 1992, Vol 79, Num 4, pp 843-845, issn 0006-4971Article